Bryn Mawr Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
Bryn Mawr Capital Management's CL Position: Q2 2026 in Review
Bryn Mawr Capital Management increased its Colgate-Palmolive (CL) stake by 5.6% in Q2 2026, buying an estimated $15.5K and bringing the position to 3,354 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #368.
Bryn Mawr Capital Management first reported a position in CL in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.86M in Q4 2024. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Bryn Mawr Capital Management held 3,354 shares of Colgate-Palmolive worth $308K as of Q2 2026.
- Bryn Mawr Capital Management bought 177 Colgate-Palmolive shares in Q2 2026, an estimated $15.5K.
- Colgate-Palmolive made up 0.01% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #368 holding.
- Bryn Mawr Capital Management first reported a position in Colgate-Palmolive in Q1 2022 and has held it in 16 quarters since.
- Bryn Mawr Capital Management's Colgate-Palmolive position peaked at $1.86M in Q4 2024.
- 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.